Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Found

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Found head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 35 · Grade B−

Found

Visit Found Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 81 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Found a bad call — it's best for readers who want insurance run against their clinical visits and a clinician free to move them between compounded, brand and oral routes. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
84
Supply Reliability
95
88
Transparency
90
62
Access Breadth
93
92
Clinical Oversight
92
90
Track Record
88
86
CoreAge RxBrief Score 94 · 81Found

Price, coverage & the tracker

CoreAge RxFound
Brief Score94/100 (A)81/100 (B−)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still sits before a ~$30 per-visit copay
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules
CoverageUS only; restrictions by state, confirmed at intakeAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Found: Headline unchanged, but our $129 line was wrong: the published floor is $99 and it requires a 3-, 6- or 12-month plan.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.